Impact of metabolic syndrome on ablation-outcome in patients with atrial fibrillation: A systematic review

Sanghamitra Mohanty, Luigi Di Biase, Prasant Mohanty, Pasquale Santangeli, Bai Rong, Trivedy Chintan, David Burkhardt, Joseph G. Gallinghouse, Rodney Horton, Javier E. Sanchez, Shane Bailey, Jason Zagrodzky, Andrea Natale

Research output: Contribution to journalReview article

Abstract

Metabolic syndrome (MS), a pro-inflammatory state with hypertension, diabetes, dyslipidemia and obesity is presumed to be a close associate of atrial fibrillation (AF). However, the exact mechanism by which MS facilitates perpetuation of AF is yet to be fully understood. Moreover, the impact of the components of MS as well as MS as a group, on ablation-outcome in AF is not clearly elucidated until now. This review has compiled the results from major studies that have looked into those risk factors and defined their significance in influencing ablation-outcome in AF. It has also overviewed the impact of life-style changes that might improve the success rate of AF-Ablation by effectively addressing the different constituents of MS.

Original languageEnglish (US)
Pages (from-to)28-36
Number of pages9
JournalJournal of Atrial Fibrillation
Volume5
Issue number5
StatePublished - Feb 1 2013
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Mohanty, S., Biase, L. D., Mohanty, P., Santangeli, P., Rong, B., Chintan, T., Burkhardt, D., Gallinghouse, J. G., Horton, R., Sanchez, J. E., Bailey, S., Zagrodzky, J., & Natale, A. (2013). Impact of metabolic syndrome on ablation-outcome in patients with atrial fibrillation: A systematic review. Journal of Atrial Fibrillation, 5(5), 28-36.